Ensysce Biosciences (ENSC) Price to Sales (2020 - 2025)

Ensysce Biosciences (ENSC) has reported Price to Sales for 6 consecutive years, with 15.29 the latest figure, recorded in Q3 2025.

• On a quarterly basis, Price to Sales rose 2102.0% year-over-year to 15.29 in Q3 2025; TTM through Sep 2025 was 1.68, a 212.89% increase from a year earlier, with the FY2024 full-year figure at 1.09, up 1.31% from the prior year.
• Price to Sales was 15.29 for Q3 2025 at Ensysce Biosciences, up from 3.89 in the prior quarter.
• Over five years, Price to Sales peaked at 523.26 in Q2 2021 and troughed at 0.69 in Q3 2024.
• A 5-year average of 68.56 and a median of 14.72 in 2024 frame the typical range for Price to Sales.
• Across the five-year window, Price to Sales slumped 98.05% in 2022 and surged 2102.0% in 2025, its largest moves.
• Over 5 years, Price to Sales stood at 57.95 in 2021, then tumbled by 98.05% to 1.13 in 2022, then jumped by 312.48% to 4.66 in 2023, then fell by 6.52% to 4.36 in 2024, then jumped by 250.96% to 15.29 in 2025.
• The last three Price to Sales figures came in at 15.29 (Q3 2025), 3.89 (Q2 2025), and 3.19 (Q1 2025), per Business Quant data.